Contact
Please use this form to send email to PR contact of this press release:
Immix Biopharma Announces FDA Approval of IND Application for CAR-T NXC-201, Enabling U.S. Patient Dosing
TO:
Please use this form to send email to PR contact of this press release:
Immix Biopharma Announces FDA Approval of IND Application for CAR-T NXC-201, Enabling U.S. Patient Dosing
TO: